Second‐line chemotherapy for advanced biliary tract cancer after failure of the gemcitabine‐platinum combination: A large multicenter study by the Association des Gastro‐Entérologues Oncologues
Brieau, Bertrand, Dahan, Laetitia, De Rycke, Yann, Boussaha, Tarek, Vasseur, Philippe, Tougeron, David, Lecomte, Thierry, Coriat, Romain, Bachet, Jean‐Baptiste, Claudez, Pierre, Zaanan, Aziz, Soibinet, Pauline, Desrame, Jérome, Thirot‐Bidault, Anne, Trouilloud, Isabelle, Mary, Florence, Marthey, Lysiane, Taieb, Julien, Cacheux, Wulfran, Lièvre, Astrid
Published in Cancer (15.09.2015)
Published in Cancer (15.09.2015)
Get full text
Journal Article
Association Between Low Trough Levels of Vedolizumab During Induction Therapy for Inflammatory Bowel Diseases and Need for Additional Doses Within 6 Months
Williet, Nicolas, Boschetti, Gilles, Fovet, Marion, Di Bernado, Thomas, Claudez, Pierre, Del Tedesco, Emilie, Jarlot, Camille, Rinaldi, Leslie, Berger, Anne, Phelip, Jean-Marc, Flourie, Bernard, Nancey, Stéphane, Paul, Stéphane, Roblin, Xavier
Published in Clinical gastroenterology and hepatology (01.11.2017)
Published in Clinical gastroenterology and hepatology (01.11.2017)
Get full text
Journal Article
Sa1939 Serum Vedolizumab Assay at Week 6 Predicts Sustained Clinical Remission and Lack of Recourse to Optimisation in IBD
Paul, Stephane, Williet, Nicolas, Claudez, Pierre, Fauvet, Marion, Del Tedesco, Emilie, Jarlot, Camille, Phelip, Jean Marc, Genin, Christian, Depince, Anne, Roblin, Xavier
Published in Gastroenterology (New York, N.Y. 1943) (01.04.2016)
Published in Gastroenterology (New York, N.Y. 1943) (01.04.2016)
Get full text
Journal Article